References
- Hammer S M, Katzenstein D A, Hughes M D, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med 1996; 335: 1081–1090
- Hogg R S, Yip B, Chan K J, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 2568–2577
- Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 1999; 353: 863–868
- Wood E, Hogg R S, Bonner S, et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA 2004; 292: 1175–1177
- Wood E, Montaner J S, Bangsberg D, et al. Extending access to HIV antiretrviral therapy to marginalized populations in the developed world. AIDS 2003; 17: 2419–2427
- Wood E, Montaner J S, Schechter M T, Tyndall M W, O'Shaughnessy M V, Hogg R S. Prevalence and correlates of untreated HIV-1 infection in the era of modern antiretroviral therapy. J Infect Dis 2003; 188: 1164–1170
- Allen S, Meinzen-Derr J, Kautzman M, et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 2003; 17: 733–740
- Bentley M E, Spratt K, Shepherd M E, et al. HIV testing and counseling among men attending sexually transmitted disease clinics in Pune, India: changes in condom use and sexual behavior over time. AIDS 1998; 12: 1869–1877
- Strathdee S A, Palepu A, Cornelisse P G, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998; 280: 547–549